Page results
-
University College Hospital's Outpatients department sees many patients, covering a variety of different specialties.
-
Contact details of clinical lead adults and lead paediatrics
-
Information for the Camden Sickle Cell and Thalassaemia Service
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
The full integration of intra-oral scanners with Epic improves efficiency and enhances patient experience by significantly reducing appointment times and appointment-to-treatment times so patients receive the right care faster.
-
A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.
-
Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area.
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
I worked as a senior directorate accountant in finance in the NHS across a wide range of directorates, both corporate and clinical areas, working closely with these directorates on their financial plans, monitoring and forward planning.
-
We are excited to share news that Genomics England has launched an initiative that will directly benefit patients from underrepresented populations such as those living with sickle cell disorder.
File results
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0393 - Translation service/ communication spend
-
FOI/2024/0394 - Private maternity services 2012, 2016, 2018, 2022 and 2023
-
FOI/2024/0395 - Treatment and services for duchenne muscular dystrophy
-
FOI/2024/0400 - Gestational Diabetes Mellitus (GDM) screening and fetal outcomes
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024